ALTERED PULMONARY INTERLEUKIN-6 SIGNALING IN PRETERM INFANTS DEVELOPING BRONCHOPULMONARY DYSPLASIA

REFERENCES

• Bland R D. Neonatal chronic lung disease in the post-surfactant era. Biol Neonate 2005; 88: 181–191
   PubMedGoogle Scholar
• Chess P R, D'Angio C T, Pryhuber G S, Maniscalco W M. Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 171–178
   PubMed Web of Science ®Google Scholar
• Bagchi A, Viscardi R M, Taciak V, Ensor J E, McCrea K A, Hasday J D. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994; 36: 244–252
   PubMed Web of Science ®Google Scholar
• Choi C W, Kim B I, Kim H S, Park J D, Choi J H, Son D W. Increase of interleukin-6 in tracheal aspirate at birth: predictor of subsequent bronchopulmonary dyspülasia in preterm infants. Acta Paediatr 2006; 95: 38–43
   PubMed Web of Science ®Google Scholar
• Taga T, Kishimoto T. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr Opin Immunol 1995; 7: 17–23
   PubMed Web of Science ®Google Scholar
• Rose-John S, Heinrich P C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994; 300: 281–290
   PubMed Web of Science ®Google Scholar
• Jostock T, Mullberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath M F, Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 2001; 268: 160–167
   PubMedGoogle Scholar
• Rose-John S, Waetzig G H, Scheller J, Grötzinger J, Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 2007; 11: 613–624
   PubMed Web of Science ®Google Scholar
• Kallen K J. The role of transsignaling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 2002; 1592: 323–343
   PubMed Web of Science ®Google Scholar
• An H, Nishimaki S, Ohyama M, Haruki A, Naruto T, Kobayashi N, Sugai T, Kobayashi Y, Mori M, Seki K, Yokota S. Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants. Am J Obstet Gynecol 2004; 191: 1649–1654
   PubMed Web of Science ®Google Scholar
• Walsh M C, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon L, Jobe A. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006; 117: 52–56, (3 Pt 2)
   PubMed Web of Science ®Google Scholar
• Taga T. IL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130. Res Immunol 1992; 143: 737–739
   PubMedGoogle Scholar
• Müllberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich P C, Rose-John S. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 1993; 23: 473–480
   PubMed Web of Science ®Google Scholar
• Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos G D, Taga T, Kishimoto T. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 1993; 82: 1120–1126
   PubMed Web of Science ®Google Scholar
• Ehrenkranz R A, Walsh M C, Vohr B R, Jobe A H, Wright L L, Fanaroff A A, Wrage L A, Poole K. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353–1360
   PubMed Web of Science ®Google Scholar
• Vohr B R, Wright L L, Poole W K, McDonald S A. Neurodevelopmental outcomes of extremely low birth weight infants < 32 weeks' gestation between 1993 and 1998. Pediatrics 2005; 116: 635–643
   PubMed Web of Science ®Google Scholar
• Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 2001; 18: 1–9
   PubMed Web of Science ®Google Scholar
• Jobe A H, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998; 53: 81–94
   PubMed Web of Science ®Google Scholar
• Jobe A J. The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641–643
   PubMed Web of Science ®Google Scholar
• Viscardi R M, Muhumuza C K, Rodriguez A, Fairchild K D, Sun C C, Gross G W, Campbell A B, Wilson P D, Hester L, Hasday J D. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004; 55: 1009–1017
   PubMed Web of Science ®Google Scholar
• Speer C P. Pulmonary inflammation and bronchopulmonary dysplasia. J Perinatol 2006; 26: 56–6
   Web of Science ®Google Scholar
• Yoon B H, Romero R, Kim K S, Park J S, Ki S H, Kim B I, Jun J K. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999; 181: 773–779
   PubMed Web of Science ®Google Scholar
• Munshi U K, Niu J O, Siddiq M M, Parton L A. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997; 24: 331–336
   PubMed Web of Science ®Google Scholar
• Niu J O, Munshi U K, Siddiq M M, Parton L A. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J Pediatr 1998; 132: 965–970
   PubMed Web of Science ®Google Scholar
• LoMonaco M B, Barber C M, Sinkin R A. Differential cytokine mRNA expression by neonatal pulmonary cells. Pediatr Res 1996; 39: 248–252
   PubMed Web of Science ®Google Scholar
• Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw R J. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996; 40: 250–256
   PubMed Web of Science ®Google Scholar
• Rose-John S, Scheller J, Elson G, Jones S A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006; 80: 227–236
   PubMed Web of Science ®Google Scholar
• Park W Y, Goodman R B, Steinberg K P, Ruzinski J T, Radella F, Park D R. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164: 1896–1903
   PubMed Web of Science ®Google Scholar
• Hurst S M, Wilkinson T S, McLoughlin R M, Jones S, Horiuchi S, Yamamoto N, Rose-John S, Fuller G M, Topley N, Jones S A. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14: 705–714
   PubMed Web of Science ®Google Scholar
• McLoughlin R M, Witowski J, Robson R L, Wilkinson T S, Hurst S M, Williams A S. Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 2003; 112: 598–607
   PubMed Web of Science ®Google Scholar
• Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding C A, Jones S A, Rose-John S, Scheller J. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 2007; 110: 1748–1755
   PubMed Web of Science ®Google Scholar
• Gomez M I, Sokol S H, Muir A B, Soong G, Bastien J, Prince A S. Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling. J Immunol 2005; 175: 1930–1936
   PubMed Web of Science ®Google Scholar
• Greene C, Lowe G, Taggart C, Gallagher P, McElvaney N, O'Neill S. Tumor necrosis factor-alpha-converting enzyme: its role in community-acquired pneumonia. J Infect Dis 2002; 186: 1790–1796
   PubMed Web of Science ®Google Scholar
• Kotecha S, Chan B, Azam N, Silverman M, Shaw R J. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar Lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal 1995; 72: F90–F96
   PubMed Web of Science ®Google Scholar
• Meyer K C, Zimmerman J J. Inflammation and surfactant. Paediatr Respir Rev 2002; 3: 308–314
   PubMedGoogle Scholar
• Krause M F, Wiemann T, Reisner A, Orlowska-Volk M, Köhler H, Ankermann T. Surfactant reduces extravascular lung water and invasion of polymorphonuclear leukocytes into the lung in a piglet model of airway lavage. Pulm Pharmacol Ther 2005; 18: 129–139
   PubMed Web of Science ®Google Scholar
• Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak J F, Lehr H A, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle P R, Rose-John S, Neurath M F. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 2000; 6: 583–588
   PubMed Web of Science ®Google Scholar
• Nowell M A, Richards P J, Horiuchi S, Yamamoto N, Rose-John S, Topley N, Williams A S, Jones S A. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol 2003; 171: 3202–3209
   PubMed Web of Science ®Google Scholar
• Doganci A, Eigenbrod T, Krug N, De Sanctis G T, Hausding M, Erpenbeck V J, Haddad el-B, Lehr H A, Schmitt E, Bopp T, Kallen K J, Herz U, Schmitt S, Luft C, Hecht O, Hohlfeld J M, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Renz H, Neurath M F, Galle P R, Finotto S. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest 2005; 115: 313–325
   PubMed Web of Science ®Google Scholar
• Dargaville P A, South M, Vervaart P, McDougall P N. Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 1999; 160: 778–784
   PubMed Web of Science ®Google Scholar